Number of Shares
4.58 Mil
Current Holdings Value*
$153.82 Mil
% of Portfolio
1.48%
Total Estimate Gain
$22.58 Mil
% of Total Estimate Gain
16.10%

DRIEHAUS CAPITAL MANAGEMENT LLC's Xenon Pharmaceuticals Inc Holding Summary

As of 2025-03-31, DRIEHAUS CAPITAL MANAGEMENT LLC held 4.58 Mil shares of Xenon Pharmaceuticals Inc(XENE), totaling $153.82 Mil. This investment constitutes 1.48% of their stock portfolio, and DRIEHAUS CAPITAL MANAGEMENT LLC now holds 5.99% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.

The initial trade took place in 2020Q1. And since then DRIEHAUS CAPITAL MANAGEMENT LLC has made 14 purchases of XENE, at an average price of $27.25, for a total of 5.14 Mil shares. In addition, there have been 7 sales at an average price of $36.79 for 559,900.00 shares. Based on historical transaction data and XENE's current price of $31.01, DRIEHAUS CAPITAL MANAGEMENT LLC's estimated gain on his XENE holdings is $22.58 Mil, reflecting a 16.10% gain to date.

DRIEHAUS CAPITAL MANAGEMENT LLC XENE ($31.01) Holding Chart

DRIEHAUS CAPITAL MANAGEMENT LLC XENE ($31.01) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1